Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Exit

Uhuru to connect to UK's public markets
IoT management software provider Uhuru plans to file for an offering that would allow Salesforce, Mitsui, SoftBank, NEC and NGK Spark Plug to exit.
10x Genomics gees up for $100m IPO
SoftBank-backed medical research technology provider 10x Genomics, valued at nearly $1.3bn as of this year, has filed to go public.
IGM Biosciences eyes public markets spot
Anti-cancer antibody developer IGM has filed to raise up to $100m, weeks after securing $102m in a Haldor Tops√łe-backed series C round.
SpringWorks sparks $115m IPO filing
GlaxoSmithKline and Pfizer are in line for exits after oncology drug developer SpringWorks filed to float on the Nasdaq Global Market.
Satsuma sets course for public markets
Shin Nippon spinoff Satsuma has filed for an $86.3m initial public offering that will fund phase 3 trials of its migraine candidate.
TSE gives Giftee IPO permission
The digital gifting platform, which counts KDDI as its largest investor, expects to raise approximately $51.7m when it floats in Tokyo.
Naspers to gamble on $100m Dream11 investment
Naspers is exploring a $100m secondary investment in the fantasy sports platform, though corporate backer Tencent does not appear to be among the likely sellers.

Other News

Cloudflare to cross over to public markets
The Alphabet, Baidu, Microsoft and Qualcomm-backed hosting services provider has filed to raise $100m in its IPO, five months after raising money at a reported $3.2bn valuation.
Chatwork talks its way to Tokyo IPO
Tokyo Stock Exchange has approved an initial public offering for enterprise communication platform Chatwork that will enable GMO Venture Partners to exit.
Vreal slips into the night
VR streaming technology creator Vreal has reached the end of the road having previously raised money from Intel Capital and Akatsuki Entertainment Technology Fund.
We Company releases billion-dollar IPO filing
SoftBank-backed workspace provider We Company has filed for an initial public offering in which it reportedly expects to raise up to $4bn.
Jazz carries away Cavion in $313m deal
Novartis and Eli Lilly are exiting the neurological disease therapy developer in an acquisition that will involve $52.5m upfront and up to $250m in milestone payments.
TopFunnel sucks in Clara Labs
Virtual scheduling assistant developer Clara has been acquired by recruitment services provider TopFunnel two years after raising $7m from investors including Slack Fund.

Editor's Picks

We Company releases billion-dollar IPO filing
SoftBank-backed workspace provider We Company has filed for an initial public offering in which it reportedly expects to raise up to $4bn.
BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
Slack slides into public markets
The SoftBank, Comcast and Alphabet-backed communication platform developer saw its shares pop and its market cap climb nearly 50% to $19.5bn following its direct listing.
test reg

Login